This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Talk:Autism spectrum: Difference between revisions
Jump to navigation
Jump to search
>David Hedlund Added http://www.ncbi.nlm.nih.gov/pubmed/20150873 |
>David Hedlund Added https://www.ncbi.nlm.nih.gov/pubmed/30196397 |
||
| Line 17: | Line 17: | ||
===Entacogens=== | ===Entacogens=== | ||
* [https://www.ncbi.nlm.nih.gov/pubmed/25818246 MDMA-assisted therapy: A new treatment model for social anxiety in autistic adults.] | * [https://www.ncbi.nlm.nih.gov/pubmed/25818246 MDMA-assisted therapy: A new treatment model for social anxiety in autistic adults.] | ||
* [https://www.ncbi.nlm.nih.gov/pubmed/30196397 Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study.] | |||
Revision as of 23:59, 14 November 2018
Endocannabinoids
For substances, see Cannabinoid.
- Cannabidiol as a suggested candidate for treatment of autism spectrum disorder.
- Endocannabinoid Signaling in Autism
- The Endocannabinoid System and Autism Spectrum Disorders: Insights from Animal Models
- Role of Endocannabinoids on Neuroinflammation in Autism Spectrum Disorder Prevention
- The Endocannabinoid System and Autism Spectrum Disorders: Insights from Animal Models.
Serotonin
For substances, see Serotonin.
- Cortical serotonin 5-HT2A receptor binding and social communication in adults with Asperger's syndrome: an in vivo SPECT study.
- Elevated urine levels of bufotenine in patients with autistic spectrum disorders and schizophrenia.
- Flashback to the 1960s: LSD in the treatment of autism.